influenza
viru
coronaviru
epidem
pandem
occur
success
worldwid
throughout
earli
centuri
epidem
pandem
pose
major
threat
human
health
outlin
critic
role
host
cell
proteas
influenza
viru
coronaviru
infect
highlight
antivir
therapeut
strategi
target
pathogen
microorgan
alway
major
threat
human
health
black
death
etiolog
caus
yersinia
pesti
estim
kill
europ
total
popul
centuri
influenza
pandem
kill
approxim
million
peopl
worldwid
today
mani
pathogen
microorgan
pose
great
threat
human
health
smallpox
yersinia
pesti
becom
extinct
control
due
advanc
medic
technolog
public
health
system
etiolog
agent
influenza
viru
coronaviru
howev
man
yet
found
effect
control
method
centuri
alon
four
largescal
respiratori
viru
epidem
pandem
occur
worldwid
virus
respons
sarscov
pandem
influenza
viru
merscov
asian
influenza
viru
exampl
influenza
viru
emerg
china
mer
swept
saudi
arabia
continu
spread
even
mer
case
south
korea
vaccin
effect
mean
control
pandem
genet
mutat
could
make
vaccin
ineffect
via
induc
nonprotect
respons
newli
emerg
virus
would
leav
even
vaccin
popul
highli
vulner
antivir
drug
target
viral
protein
also
eventu
lose
effect
viral
mutat
occur
viru
strain
resist
amantadin
oseltamivir
alreadi
emerg
among
asian
influenza
viru
pandem
influenza
viru
emerg
drugresist
strain
highlight
need
novel
antivir
therapeut
approach
recent
great
deal
evid
suggest
transmembran
proteas
serin
type
ii
transmembran
serin
proteas
ttsp
play
critic
role
sar
abbrevi
androgen
receptor
element
aebsf
benzenesulfonyl
fluorid
hydrochlorid
bhh
bromhexin
hydrochlorid
cov
coronaviru
serin
proteas
est
ethyl
ester
fda
food
drug
administr
hat
human
airway
trypsinlik
proteas
hepatocyt
growth
factor
activ
inhibitor
hgf
hepatocyt
growth
factor
ifitm
interferoninduc
transmembran
protein
matrix
mspl
transmembran
proteas
serin
plasminogen
activ
inhibitor
proteas
activ
receptor
ppmo
peptideconjug
phosphorodiamid
morpholino
oligom
rb
receptor
bind
subdomain
human
tracheal
epitheli
transmembran
proteas
serin
transmembran
proteas
serin
ttsp
type
ii
transmembran
serin
proteas
vrnp
viral
ribonucleoprotein
mer
coronaviru
cov
asian
influenza
viru
sever
subtyp
influenza
virus
infect
indic
target
could
novel
antivir
strategi
treat
coronaviru
low
pathogen
influenza
viru
infect
gene
locat
human
chromosom
fig
signific
featur
gene
sever
androgen
receptor
element
are
locat
upstream
transcript
start
site
first
intron
shown
fig
gene
encod
predict
protein
amino
acid
anchor
plasma
membran
convert
form
autocatalyt
cleavag
cleavag
matur
proteas
mostli
membranebound
yet
notic
portion
liber
extracellular
milieu
proteas
catalyt
domain
contain
catalyt
triad
consist
amino
acid
residu
correspond
chymotrypsinogen
predominantli
express
prostat
rel
lower
level
express
lung
colon
liver
kidney
pancrea
lung
cancer
cell
line
prostat
cancer
cell
line
lncap
express
androgendepend
manner
demonstr
activ
proteas
activ
receptor
gprotein
coupl
receptor
activ
caus
upregul
matrix
key
proteas
metastasi
tumor
cell
furthermor
hepatocyt
growth
factor
hgf
promot
cmet
receptor
tyrosin
kinas
signal
induc
proinvas
epithelialmesenchym
transit
phenotyp
prostat
cancer
cell
recent
studi
suggest
play
role
cell
membraneanchor
mediat
cancer
pain
pain
gener
howev
mice
show
obviou
phenotyp
abnorm
death
infertil
visibl
sick
exact
physiolog
function
vivo
remain
unknown
specul
may
contribut
special
nonvit
function
appar
certain
condit
viral
entri
first
step
viral
replic
cycl
entri
envelop
virus
host
cell
case
requir
virion
bind
cell
surfac
receptor
fuse
hostcel
membran
process
control
viral
envelop
glycoprotein
viru
entri
coordin
receptor
bind
process
involv
numer
conform
chang
viral
envelop
glycoprotein
influenza
viru
ha
class
viral
fusion
protein
two
function
subunit
fig
ha
synthes
fusioninact
precursor
proper
proteolyt
cleavag
disulfid
bound
subunit
form
homotrim
structur
three
chain
seen
form
stem
embrac
nand
ctermin
segment
main
central
portion
chain
form
globular
head
domain
sit
top
stem
fusion
peptid
consist
mainli
apolar
residu
locat
nterminu
buri
hydrophob
pocket
form
partial
fusion
domain
proteolyt
cleavag
ha
fragment
critic
step
viru
infect
endow
ha
fusion
compet
precursor
ha
cleavag
liber
fusion
peptid
insert
target
membran
fusion
cleavag
allow
ha
metast
conform
trigger
acid
ph
endosom
undergo
structur
rearrang
requir
fusion
proteolyt
cleavag
receptor
bind
subdomain
attach
sialic
receptor
target
membran
surfac
host
cell
trigger
intern
virion
endocyt
pathway
matur
endosom
acid
environ
endosom
trigger
rearrang
provok
full
exposur
releas
fusion
peptid
inner
pocket
subsequ
low
phtrigger
reconform
caus
fusion
peptid
insert
target
endosom
membran
form
intermedi
structur
call
prehairpin
sever
prehairpin
undergo
structur
rearrang
bend
back
hing
point
drive
viral
cellular
membran
close
proxim
induc
hemifus
complet
fusion
ultim
gener
fusion
pore
allow
viral
genet
materi
escap
cytosol
fig
class
viral
fusion
protein
coronaviru
spike
glycoprotein
share
mani
structur
mechanist
featur
influenza
viru
ha
coronaviru
protein
contain
two
function
domain
fig
harbor
receptorbind
domain
contain
function
element
involv
membran
fusion
distinct
featur
coronaviru
protein
harbor
one
proteolyt
cleavag
site
first
identifi
cleavag
site
locat
boundari
anoth
within
upstream
put
fusion
peptid
call
cleavag
spike
glycoprotein
domain
remain
associ
noncoval
disulfid
bond
import
fig
schemat
diagram
genom
locat
distinct
influenza
viru
ha
sinc
two
domain
held
coval
domain
may
shed
stalk
domain
protein
studi
suggest
hat
ttsp
transmembran
proteas
serin
homo
sapien
serin
proteas
homo
sapien
transmembran
proteas
serin
mspl
cleav
human
avian
influenza
viru
ha
protein
arginin
residu
cleavag
site
shown
fig
hat
cleav
newli
synthes
ha
releas
progeni
virion
ha
incom
virus
incorpor
host
cell
cleav
nascent
ha
within
host
cell
involv
proteolyt
activ
ha
incom
virion
specul
solubl
form
possess
minim
enzym
activ
insuffici
support
cleavag
ha
anim
model
infect
wildtyp
mice
influenza
viru
influenza
viru
led
sever
diseas
mortal
rate
respect
wherea
mice
virus
pathogen
exampl
knockout
mice
highli
toler
challeng
infect
influenza
viru
mouseadapt
influenza
viru
acalifornia
lethal
dose
wt
mice
result
demonstr
essenti
role
pneumotrop
pathogen
influenza
viru
subtyp
influenza
virus
vivo
sarscov
protein
cleav
wide
varieti
host
proteas
hat
mspl
factor
xa
cathepsin
lb
shown
sarscov
enter
cell
via
two
distinct
pathway
one
mediat
cell
surfac
done
cathepsin
lb
endosom
fig
serin
proteas
inhibitor
camostat
effect
protect
mice
infect
otherwis
lethal
sarscov
death
treatment
serin
cathepsin
inhibitor
fail
improv
surviv
significantli
achiev
camostat
alon
indic
sarscov
propag
pathogenesi
mediat
rather
cathepsin
vivo
kawas
et
al
found
sarscov
entri
increas
presenc
convers
sirna
target
caus
fivefold
decreas
sarscov
entri
cell
moreov
level
sarscov
rna
ninefold
higher
cell
express
activ
cell
express
enzymat
inact
western
blot
analysi
reveal
sarscov
cleav
sever
fragment
upon
express
ciscleavag
infect
cell
well
upon
contact
sarscov
sexpress
cell
cell
transcleavag
ciscleavag
result
releas
sarscov
fragment
cellular
supernat
may
interfer
antibodymedi
neutral
transcleavag
activ
sarscov
target
cell
allow
effici
sarscov
sdriven
viral
fusion
addit
activ
sarscov
interfer
inhibit
sarscoa
interferoninduc
transmembran
protein
ifitm
class
interferoninduc
host
cell
protein
inhibit
entri
sever
envelop
virus
collect
obtain
evid
suggest
play
import
role
sarscov
infect
host
proteas
involv
prime
merscov
includ
hat
mspl
furin
endosom
cathepsin
bl
similar
sarscov
infect
merscov
infect
larg
depend
activ
endogen
ttsp
camostat
treatment
alon
effect
camostat
plu
est
cathepsin
inhibitor
inhibit
viru
entri
cell
indic
domin
role
merscov
entri
inde
augment
merscov
infect
vero
cell
noncatalyt
significantli
abrog
entri
merscov
compar
normal
although
host
proteas
hat
mspl
suggest
involv
prime
merscov
express
level
lung
tissu
consider
lower
indic
limit
role
proteas
viral
propag
host
lung
tissu
observ
demonstr
merscov
infect
larg
depend
activ
endogen
detail
shown
fig
redund
physiolog
function
along
critic
role
influenza
viru
influenza
viru
sarsand
merscov
infect
suggest
promis
target
drug
develop
one
possibl
drug
aprotinin
pdb
id
polypeptid
consist
amino
acid
residu
purifi
bovin
lung
polypeptid
inhibit
serin
proteas
suppress
cleavag
influenza
viru
ha
thu
limit
reproduct
influenza
viru
aerosol
inhal
aprotinin
observ
therapeut
effect
influenza
parainfluenza
mice
human
smallparticl
aerosol
aprotinin
approv
russia
treatment
patient
mildtomoder
influenza
infect
camostat
serin
proteas
inhibitor
use
treatment
cancer
pancreat
liver
fibrosi
human
tracheal
epitheli
hte
cell
treat
camostat
concentr
mgml
influenza
viru
titer
cultur
supernat
significantli
reduc
furthermor
camostat
administr
protect
mice
infect
influenza
viru
recent
studi
demonstr
inhibit
camostat
led
reduct
sarscov
titer
cell
drug
also
effect
protect
mice
sarscov
infect
surviv
rate
addit
camostat
concentr
mm
impair
merscov
entri
cell
amount
viral
rna
cultur
supernat
cell
reduc
presenc
mm
camostat
three
day
post
merscov
infect
recent
nafamostat
serin
proteas
inhibitor
report
block
merscov
infect
vitro
via
inhabit
activ
reduc
viral
entri
concentr
low
nm
effect
camostat
addit
bromhexin
hydrochlorid
bhh
ingredi
mucolyt
cough
suppress
also
effect
attenu
prostat
cancer
metastasi
mice
furthermor
show
specif
inhibit
mm
given
bhh
fdaapprov
drug
signific
advers
effect
could
use
treatment
influenza
viru
coronaviru
infect
inhibitor
fdaapprov
serin
proteas
inhibitor
benzenesulfonyl
fluorid
hydrochlorid
aebsf
leupeptin
also
exhibit
vari
degre
antivir
activ
pretreat
mice
aebsf
prior
influenza
viru
infect
significantli
reduc
weight
loss
result
faster
recoveri
compar
seen
untreat
mice
ovomucoid
pdb
id
trypsin
inhibitor
effect
aprotinin
suppress
propag
influenza
viru
concentr
mm
recent
studi
demonstr
compound
could
inhibit
nanomolar
rang
potent
deriv
inhibit
ki
valu
nm
suppress
influenza
viru
propag
human
airway
epitheli
cell
dosedepend
manner
also
report
three
benzamidinederiv
peptid
mimet
compound
suppress
influenza
viru
infect
vari
degre
hatexpress
cell
dittmann
et
al
report
plasminogen
activ
inhibitor
pdb
id
effici
inhibit
trypsinand
cleavag
ha
suppress
influenza
viru
propag
ex
vivo
vivo
addit
hepatocyt
growth
factor
activ
inhibitor
pdb
id
report
effici
inhibit
hacleav
proteas
also
shown
inhibit
influenza
viru
infect
vitro
protect
anim
influenza
viru
infect
mous
model
result
suggest
local
administr
respiratori
tract
might
new
therapeut
approach
treatment
influenza
viru
coronaviru
respiratori
viru
infect
requir
host
proteasedriven
matur
noteworthi
none
compound
protein
describ
inhibitor
nonspecif
natur
inhibitor
may
caus
unpredict
side
effect
instanc
food
drug
administr
fda
found
aprotinin
increas
risk
kidney
failur
heart
diseas
stroke
result
ban
restrict
statu
drug
countri
therefor
necessari
develop
inhibitor
specif
target
auser
et
al
design
synthes
singlestrand
dnalik
antisens
agent
low
toxic
call
peptideconjug
phosphorodiamid
morpholino
oligom
ppmo
fig
readili
enter
cell
alter
splice
pattern
premrna
cell
treat
ppmo
express
incomplet
enzymat
inact
form
consequ
cleavag
ha
impair
influenza
viru
titer
reduc
fold
cell
devan
et
al
develop
polyamid
compound
interact
consensu
attempt
inhibit
growth
prostat
cancer
cell
studi
show
polyamid
moder
inhibit
express
bind
promot
suppress
rna
transcript
like
function
import
stabil
juxtapos
enhancertarget
gene
promot
loop
enabl
optim
gene
express
indic
cell
membraneperm
polyamid
specif
interact
particular
control
regul
express
thu
possibl
polyamid
compound
target
would
specif
suppress
asian
influenza
viru
subtyp
influenza
virus
sar
merscov
infect
structur
small
molecular
inhibitor
overment
summar
fig
one
direct
impact
recent
increas
popul
mobil
global
spread
infecti
diseas
sinc
turn
centuri
influenza
coronaviru
epidem
occur
worldwid
emerg
drugresist
virus
new
virus
highlight
need
novel
antivir
approach
strategi
target
cellular
factor
rel
new
antivir
strategi
may
reduc
avoid
emerg
escap
mutant
one
host
factor
essenti
pneumotrop
pathogen
asian
influenza
viru
sever
subtyp
influenza
virus
infect
enzym
also
play
import
role
sarscov
merscov
infect
indic
promis
drug
target
treatment
viral
infect
although
fdaapprov
inhibitor
specif
inhibit
yet
avail
drug
camostat
nafamostat
inhibitori
activ
varieti
serin
proteas
approv
treatment
diseas
also
suppress
influenza
viru
coronaviru
infect
drug
inhibit
vitro
vivo
drug
reposit
may
help
develop
novel
measur
inhibit
effici
viral
entri
replic
taken
togeth
avail
evid
suggest
quit
like
target
new
therapeut
influenza
viru
coronaviru
infect
author
declar
conflict
interest
work
support
nation
natur
scienc
foundat
china
program
intern
supplementari
data
relat
articl
found
http
